Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...

Finger-prick dried blood sampling can accurately measure key Alzheimer’s disease biomarkers, including p-tau217, GFAP, and ...

A new study has demonstrated that Alzheimer’s disease biomarkers can be accurately detected using simple finger-prick blood ...

New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...

Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict ...

A new international study has demonstrated that Alzheimer's disease biomarkers can be accurately detected using simple finger ...

A simple, at-home fingertip blood test shows promise for early Alzheimer’s disease detection, according to a new Europe-wide ...

A groundbreaking NIHR-supported international study has shown that Alzheimer's disease biomarkers can be accurately detected using simple finger-prick blood samples. These samples can be collected at ...

A finger-prick blood test that can be mailed to a lab may offer a simpler way to detect the brain changes linked to Alzheimer ...

Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments ...

A new blood test could replace the brain scans and spinal taps currently used to diagnose Alzheimer's disease.